Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin Twice Daily Add-on to Metformin in T2DM
NCT01340664Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Janssen Pharmaceutical. Started Jul 2011; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01340664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340664.